tiprankstipranks
Circio to Showcase Gene Therapy Advances at ESGCT 2024
Company Announcements

Circio to Showcase Gene Therapy Advances at ESGCT 2024

Targovax ASA (GB:0RIS) has released an update.

Pick the best stocks and maximize your portfolio:

Circio Holding ASA, a biotechnology firm specializing in circular RNA technology for gene therapy, will present its circVec platform at the ESGCT annual meeting in October 2024. The presentation aims to highlight the platform’s superior performance over traditional mRNA-based expression systems. The company’s advancements have solidified its position as a frontrunner in the field of circular RNA therapeutics.

For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskCircio CTO Exercises Warrants Amidst RNA Tech Advances
TipRanks European Auto-Generated NewsdeskCircio Holding ASA Expands Share Capital Amid Therapeutics Focus
TipRanks European Auto-Generated NewsdeskCircio CEO Exercises Warrants Amid Biotech Advancements
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App